Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China

Posted by rob on September 27, 2010 under Uncategorized | Comments are off for this article

In conclusion, survival in HLA allele-matched URD is equivalent to MSD, but in MRD and mismatched URD is inferior
to MSD in patients with CML-CP1 undergoing allo-HSCT using different GVHD prophylaxis regimens according to donor source and
degree of HLA matching. Patients undergoing MRD/URD transplantation have an equal quality of life as patients undergoing MSD
transplantation.

Content Type Journal ArticleDOI 10.1007/s00277-010-1081-3Authors
Qi-fa Liu, Department Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515 ChinaXiao-jun Xu, Department Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515 ChinaYin-kui Chen, Department Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515 ChinaJing Sun, Department Hemato…
More